Ketorolac in Breast Cancer Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Curative Breast Cancer Surgery|Inflammatory Positive/Negative Status|Pre Surgical Incision Administration
Interventions: DRUG: Ketorolac 30 mg IV|DRUG: Placebos
Sponsor: Université Catholique de Louvain
Collaborators: Anticancer Fund, Belgium